Entering text into the input field will update the search result below

Talaris Therapeutics GAAP EPS of -$0.45

May 12, 2022 5:11 PM ETTourmaline Bio, Inc. (TRML) StockBy: Gaurav Batavia, SA News Editor
  • Talaris Therapeutics press release (NASDAQ:TALS): Q1 GAAP EPS of -$0.45.
  • $225.5 million in cash, cash equivalents and marketable securities compared with $140.1 million as of March 31, 2021.

Recommended For You

More Trending News

About TRML Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
TRML--
Tourmaline Bio, Inc.